265
Views
13
CrossRef citations to date
0
Altmetric
Review

Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa

Pages 1439-1446 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ashagrachew Tewabe Yayehrad, Gebremariam Birhanu Wondie & Tesfa Marew. (2022) Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes. Infection and Drug Resistance 15, pages 413-426.
Read now
Eun Lee & Soo-Jong Hong. (2019) Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients. Expert Opinion on Pharmacotherapy 20:8, pages 1025-1036.
Read now
Sabina Antoniu & Doina Azoicai. (2013) Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study. Expert Opinion on Investigational Drugs 22:5, pages 671-673.
Read now

Articles from other publishers (10)

Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai & Felicita Andreotti. (2022) Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. Pharmaceutics 15:1, pages 87.
Crossref
Lucas M. Silva, Marcos V. Foguel & Maria del Pilar T. Sotomayor. (2021) Use of two functional monomers for a new approach to the synthesis of a magnetic molecularly imprinted polymer for ciprofloxacin. Journal of Materials Research and Technology 15, pages 511-523.
Crossref
Isra Khatib, Dipesh Khanal, Juanfang Ruan, David Cipolla, Francis Dayton, James D. Blanchard & Hak-Kim Chan. (2019) Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation. International Journal of Pharmaceutics 566, pages 641-651.
Crossref
Ruba S. Darweesh & Masahiro Sakagami. (2018) In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin. European Journal of Pharmaceutical Sciences 115, pages 68-76.
Crossref
Afra Torge, Stefanie Wagner, Paula S. Chaves, Edilene G. Oliveira, Silvia S. Guterres, Adriana R. Pohlmann, Alexander Titz, Marc Schneider & Ruy C.R. Beck. (2017) Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis. International Journal of Pharmaceutics 527:1-2, pages 92-102.
Crossref
Roxana Jijie, Alexandre Barras, Florina Teodorescu, Rabah Boukherroub & Sabine Szunerits. (2017) Advancements on the molecular design of nanoantibiotics: current level of development and future challenges. Molecular Systems Design & Engineering 2:4, pages 349-369.
Crossref
Jia‐Wei Yang, Li‐Chao Fan, Hai‐Wen Lu, Xia‐Yi Miao, Bei Mao & Jin‐Fu Xu. (2015) Efficacy and safety of long‐term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta‐analysis. The Clinical Respiratory Journal 10:6, pages 731-739.
Crossref
Hartmut M. Lode. (2014) Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes. International Journal of Antimicrobial Agents 43:6, pages 497-507.
Crossref
Nadia Abed & Patrick Couvreur. (2014) Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections. International Journal of Antimicrobial Agents 43:6, pages 485-496.
Crossref
Oliver H. Wittekindt. 2014. In Vitro Toxicology Systems. In Vitro Toxicology Systems 103 121 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.